Studies were carried out to evaluate if one of the PEGosomes was compatible with two different dosage forms, suitable for people suffering from dysphagia.
Miðað var við að prófa efnilegasta PEGosome-ið í tveimur lyfjaformum sem henta fólki með kyngingar-erfiðleika.